France· FR:62296848
RHEOFLUX 3500 mg, poudre pour solution buvable en sachet-dose
A medicinal product containing troxérutine, registered in France by ETHYX PHARMACEUTICALS.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TROXÉRUTINE
- Manufacturer
- ETHYX PHARMACEUTICALS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093362784310 sachet(s) papier aluminium polyéthylène de 7,25 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Troxérutine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandPosorutinURSAPHARM Poland Sp. z o.o.
- GermanyVeno Sl 300Ursapharm Arzneimittel Gmbh
- SpainESBERIVEN 100 mg/ml SOLUCION ORALFaes Farma S.A.
- BelgiumTroxerutine Mylan 300 mgViatris GX
- CzechiaCILKANOLZentiva, k.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Venoruton, Venoruton - Gel
- Belgium · Venoruton, Venoruton Beutel
- Bulgaria · Троксевазин, Троксерутин Абр
- Czechia · Cilkanol, Venoruton
- Germany · Veno Sl 300, Veno-Pos
- Denmark · Venoruton
- Estonia · Troxevasin, Troxevasin Teva
- Spain · Esberiven, Troxerutina Cinfalab
- United Kingdom (Northern Ireland) · Paroven
- Greece · Venoruton
- Hungary · Venoruton
- Italy · Venolen, Venoruton
- Lithuania · Troxevasin, Venoruton
- Luxembourg · O-(B-Hydroxyaethyl)-Rutosidea Eg (Eurogenerics) Sa, O-(B-Hydroxyethyl)-Rutosidea Eg (Eurogenerics) Sa
- Latvia · Troxerutin Sopharma, Troxevasin
- Netherlands · Venoruton
- Poland · Posorutin, Rutoven
- Portugal · Venoruton
- Romania · Devaricid Gel, Troxerutin Chirmis
- Slovakia · Cilkanol, Venoruton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4ec4645-5b45-4313-8a6b-78089632a6bc GET /v1/drugs/f4ec4645-5b45-4313-8a6b-78089632a6bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62296848",
"date_amm": "1993-08-03",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TROXÉRUTINE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "poudre pour solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about troxérutine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.